馬雲據報已取代軟銀成阿里巴巴(09988.HK)最大股東
據內媒報道,馬雲上季一直增持阿里巴巴(09988.HK)港股,涉資約5,000萬美元,其持股比例已超過2021年底報告的4.3%。另外,美國證券交易委員會(SEC)文件披露,阿里巴巴主席蔡崇信在去年第4季掃入1.51億美元阿里ADR(BABA.US),令馬雲與蔡崇信合計持股比例超過軟銀。
近兩年來軟銀不斷減持阿里巴巴,從2022年12月的約7%降至去年5月的不足0.5%,因此馬雲目前已取代軟銀成為阿里巴巴最大股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.